Back

Proteomic profiling of genetically defined endotypes reveals molecular heterogeneity of obesity

30 August 2026 (11:33 - 11:45)
Organised by: Logo
Congress Presentation Part of: Cardiorenal metabolic disease mechanisms and treatment Obesity ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Devesh Malik

(United States of America)

4 More presentations in this session

Presentation thumbnail
Abdominal obesity leads to earlier and higher CKM syndrome risk than general obesity: a cross-sectional NHANES study
Doctor Q. Tai (Xi'an, CN)
Abstract Slides Video
Presentation thumbnail
Adiposity and diabetes in Mexican adults: evidence from observational and mendelian randomization analyses of a large prospective study
Doctor L. Friedrichs (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Cardiovascular–kidney–metabolic risk stratification and cardiorenal outcomes with SGLT2 inhibitors versus GLP-1 receptor agonists in type 2 diabetes: a global federated network study
Doctor C. Wang (Liverpool, GB)
Abstract Slides Video
Presentation thumbnail
Long-term BMI burden, its variability from childhood to adulthood and cardiovascular-kidney-metabolic syndrome in midlife: a 36-year cohort study
Doctor G. Hu (Xi'an, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiorenal metabolic disease mechanisms and treatment
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 11:33 CET
You may be interested in
thumbnail
Congress Session
Obesity and pre-diabetes: where do we stand today on prevention and treatment?
31 August 2024
thumbnail
Congress Presentation
Single-cell CRISPR perturbation in human adipocytes reveals an omnigenic core remodeling network linking CAD loci to cardiometabolic risk
28 August 2026
thumbnail
Congress Presentation
Proteomic signatures reveal why not all apolipoprotein B-containing lipoproteins are equal in atherosclerosis
31 August 2026
thumbnail
Congress Presentation
UK Biobank and the future of cardiometabolic risk stratification and therapeutic discovery
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources